Drug repurposing for disease-modifying effects in multiple system atrophy.

Transl Neurodegener · 2026 · PMC13097543 · PMID 42010648

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

Remarkably, the single MSA patient remained clinically stable over 4 weeks with a slight trend to improvement on some measures (HY 2.5 → 2.5; UPDRS-III 36 → 34; UPDRS-II 18 → 20; UPDRS-I 9 → 8; Fluency, Attention, and Speed test 44 → 46).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.